Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Giovanni Campagna

Glaucoma Specialist Saint Louis, MO Medical Doctor

NPI 1760942684 CMS profile 11303710

4901 Forest Park Ave, Dept Ophthalmology, 6Th Fl, Saint Louis, MO 63108

Open in the dashboard

General payments

$56,201

134 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Giovanni Campagna of Saint Louis, MO is reported in the CMS Open Payments database as having received $56,201 across 134 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Glaucoma Specialist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $49,545 72
2024 General $4,055 39
2023 General $1,263 11
2022 General $974 9
2021 General $365 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Giovanni Campagna
  • Glaucoma Specialist median
  • Middle half of Glaucoma Specialist
  • National median

In program year 2025, general payments to Giovanni Campagna were reported at $49,545. Among 370 Glaucoma Specialist profiles paid that year, the median was $597 and the middle half received between $244 and $1,607.

Show as a table
Year Giovanni Campagna Glaucoma Specialist median Middle half National median
2019 $0 $433 $150–$1,170 $163
2020 $0 $242 $74–$693 $114
2021 $365 $324 $122–$936 $132
2022 $974 $399 $121–$1,081 $149
2023 $1,263 $458 $190–$1,208 $160
2024 $4,055 $558 $215–$1,359 $164
2025 $49,545 $597 $244–$1,607 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Alcon Vision LLC $25,259 43 payments
  2. Glaukos Corporation $12,164 21 payments
  3. Bausch & Lomb Americas Inc. $9,003 17 payments
  4. Alcon Research LLC $5,187 3 payments
  5. New World Medical,Inc. $2,243 11 payments
  6. Sight Sciences, Inc. $1,089 12 payments
  7. AbbVie, Inc. $404 7 payments
  8. Stryker Corporation $328 1 payment
  9. RxSight Inc $154 6 payments
  10. Regeneron Healthcare Solutions, Inc. $125 1 payment
  11. Other $245 12 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $34,923 16 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,150 2 payments
  3. Food and Beverage $7,076 97 payments
  4. Travel and Lodging $5,224 17 payments
  5. Honoraria $1,500 1 payment
  6. Education $328 1 payment
Products named General payments · program years 2021–2025
  1. Voyager DSLT $22,654 20 payments
  2. HYDRUS Microstent $21,459 27 payments
  3. Travoprost Intraocular Implant - iDose $10,658 6 payments
  4. Ahmed Glaucoma Valve $2,049 9 payments
  5. Clearpath $2,049 9 payments
  6. Streamline $2,049 9 payments
  7. Kahook Dual Blade $2,049 9 payments
  8. OMNI SURGICAL SYSTEM $1,089 12 payments
  9. iDoseTR $797 7 payments
  10. NGENUITY $512 1 payment
  11. Other $3,737 98 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

134 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record